L. Boussicault

Impaired Brain Energy Metabolism in the BACHD Mouse Model of Huntington's Disease: Critical Role of Astrocyte–Neuron Interactions

F. Petit, G. Bonvento, M. Beal, 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease

P. Gubellini, F. Petit, G. Bonvento, 2016, Neurobiology of Disease.

Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides

K. Blennow, M. Millan, H. Zetterberg, 2022, Molecular Neurobiology.

Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats

K. Nave, T. Prukop, Stephanie Wernick, 2020, Journal of neuroscience research.

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

C. Pagès, J. Caboche, L. Galvan, 2016, Brain : a journal of neurology.

Cellular and Molecular Mechanisms of Neuronal Dysfunction in Huntington's Disease

J. Caboche, P. Vanhoutte, E. Roze, 2017 .

Mutations in the juxtamembrane segment of the cholesterol-binding site of APP alter its processing and promotes production of shorter, less toxic Aβ peptides

K. Blennow, M. Millan, H. Zetterberg, 2020, bioRxiv.

Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine

E. Hirsch, J. Golmard, J. Mariani, 2012, Journal of neurochemistry.

Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis

Serguei Nabirotchkin, R. Hajj, Daniel Cohen, 2020, Journal of neuroscience research.

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

C. Pagès, J. Caboche, L. Galvan, 2016, Brain : a journal of neurology.

CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.

J. Caboche, M. Potier, P. Vanhoutte, 2018, Biochimie.